Highly promising Stara Planina results prompt Raiden to accelerate drilling program

|

Published 04-JUL-2018 10:44 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

This product is classified as ‘very high risk’ in nature due to its location and geopolitical situation of the region. FinFeed advises that extra caution should be taken when deciding whether to engage in this product, however if you are not sure whether it is suitable for you we suggest you seek independent financial advice.

Raiden Resources Ltd (ASX:RDN) has provided an update on exploration activities at the Stara Planina Project, indicating that the anomaly extends over an approximate strike of 900 metres and remains open to the north.

The Stara Planina Exploration Permit is located approximately 30 kilometres south of the Timok District, a world class copper-gold region, within the Tethyan belt in Serbia.

The main target style within the permit area is bulk-mineable, intrusion-related gold-copper mineralisation.

It is worth noting that the project is located only 60 kilometres south of the globally significant Bor copper-gold mining complex and smelter.

This is a region that has been host to high-grade, long-life copper projects, and with Rio Tinto (ASX:RIO) recently entering into an agreement to inject $40 million into exploration at Stara Planina, the project has taken on a whole new profile.

Anomaly correlated with high regional copper and gold values

Preliminary results from the Induced Polarisation (IP) survey have been received from the Gradiste anomaly, which is located on the western side of the Stara Planina Project.

Indications that the anomaly extends over an approximate strike of 900 metres and remains open to the north are highly promising.

The anomaly correlated with high copper, molybdenum and gold values defined in the historical soil survey, providing management with confidence regarding the accuracy of historical data.

Overall this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.

The latest exploration results will only serve to boost investor confidence with regard to Raiden potentially being another junior such as Reservoir Minerals that has hit the big time in that region.

Large and robust drill target

Dusko Ljubojevic, Managing Director of Raiden, highlighted the significance of the latest results in saying, “The IP data suggests that, as with Aldinac, at Gradiste we are looking at another large and robust drill target, which we consider to host the potential for copper and gold intrusion-related mineralisation.

“The IP target at Gradiste is supported by historical soil anomalies, high grade trenching results, rock samples and is located adjacent to a historical underground mine.

The latest results confirm the company’s belief that the Stara Planina project is a significant target that warrants immediate follow-up exploration and preparations are being made to commence with the drilling activities as soon as possible.”

Drill testing will commence in the current quarter of 2018 in conjunction with drill testing of the Aldinac target area.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X